Journal
CARBOHYDRATE RESEARCH
Volume 342, Issue 3-4, Pages 621-626Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.carres.2006.11.014
Keywords
aminooxy; Borrelia burgdorferi; conjugation; glycolipid; glycolipoprotein; Lyme disease; oxime; vaccine
Funding
- Intramural NIH HHS [Z01 HD001313-13] Funding Source: Medline
Ask authors/readers for more resources
A novel glycolipid was synthesized that corresponds to cholesteryl palmitoyl-galactopyranoside 1 found in the spirochete Borrelia burgdorferi, the causative agent of Lyme disease. In order to fashion I in a conjugatable form, the palmitoyl residue was modified to include a terminal aldehydo, moiety that anchored the glycolipid to aminooxypropylated serum albumin using oxime chemistry. The glycolipoprotein so obtained incorporates an average of 18 glycolipid moieties per albumin molecule. The novel glycolipoprotein constructs are soluble in water and are candidates toward developing a semisynthetic vaccine against Lyme disease. (c) 2006 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available